tiprankstipranks
Nuwellis (DE:22S1)
FRANKFURT:22S1
Germany Market
22S1
Nuwellis
RESEARCH TOOLSreports

Nuwellis (22S1) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

22S1 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Nuwellis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

22S1 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:22S1 In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

22S1 Financial Forecast

22S1 Earnings Forecast

The previous quarter’s earnings for 22S1 were -€23.10.
The previous quarter’s earnings for 22S1 were -€23.10.

22S1 Sales Forecast

The previous quarter’s earnings for 22S1 were €1.71M.
The previous quarter’s earnings for 22S1 were €1.71M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on DE:22S1
Anthony Vendetti
Maxim Group
Maxim Group
―
Hold
―
Reiterated
05/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Altimmune (NASDAQ: ALT), Nuwellis (NASDAQ: NUWE) and Siegfried Holding AG (Other OTC: SGFEF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on DE:22S1
Anthony Vendetti
Maxim Group
Maxim Group
―
Hold
―
Reiterated
05/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Altimmune (NASDAQ: ALT), Nuwellis (NASDAQ: NUWE) and Siegfried Holding AG (Other OTC: SGFEF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

22S1 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
2
2
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
2
1
1
0
In the current month, 22S1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 22S1 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

22S1 Stock Forecast FAQ

What is DE:22S1’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:22S1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:22S1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Nuwellis a Buy, Sell or Hold?
      Currently, no data Available
      What is Nuwellis’s share price target?
      Currently, no data Available
      What do analysts say about Nuwellis?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Nuwellis?
      To buy shares of DE:22S1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.